id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-275447-nx45kwn6	Ehrenpreis, Eli D.	Rapid Review: Nonsteroidal Anti-inflammatory Agents and Aminosalicylates in COVID-19 Infections	2020-06-10		.txt	text/plain	2326	130	45	Since 5-ASAs are a mainstay treatment for inflammatory bowel disease, the authors review the pharmacology of both classes of drugs and discuss the potential relevance of 5-ASAs in the ongoing discussion of medication use in patients infected with COVID-19. T here has been recent controversy regarding the risk that ibuprofen (and possibly other nonsteroidal antiinflammatory drugs, NSAIDs) may worsen the clinical course of patients that are infected with COVID-19. It is therefore the purpose of this brief review to inform practitioners treating patients with 5-ASAs about the potential relationships between 5-ASAs and NSAIDs. At the time of this writing, both the World Health Organization (WHO) and the Food and Drug Administration (FDA) have not recommended the avoidance of ibuprofen in patients with known or suspected COVID-19 infections.	./cache/cord-275447-nx45kwn6.txt	./txt/cord-275447-nx45kwn6.txt